Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
34
TGA:34
Drug Approvals
ANDRIGA-5 abiraterone 500 mg film-coated tablet and prednisolone 5 mg tablet composite blister pack (437512)
- Product Name
- ANDRIGA-5 abiraterone 500 mg film-coated tablet and prednisolone 5 mg tablet composite blister pack
- Approval Date
- Jul 7, 2025
TGA
ANDRIGA-10 abiraterone 500 mg film-coated tablet and prednisolone 5 mg tablet composite blister pack (437511)
- Product Name
- ANDRIGA-10 abiraterone 500 mg film-coated tablet and prednisolone 5 mg tablet composite blister pack
- Approval Date
- Jul 7, 2025
TGA
ACTOBET 50/500 calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel tube (419553)
- Product Name
- ACTOBET 50/500 calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel tube
- Approval Date
- Jul 1, 2025
TGA
CALCIPBETA ACT 50/500 calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel tube (419552)
- Product Name
- CALCIPBETA ACT 50/500 calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel tube
- Approval Date
- Jul 1, 2025
TGA
CALCIPOTRIOL/BETAMETHASONE ACTOR 50/500 calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel tube (419554)
- Product Name
- CALCIPOTRIOL/BETAMETHASONE ACTOR 50/500 calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel tube
- Approval Date
- Jul 1, 2025
TGA
Kenkay Extra Relief Moisturising Cream (Export) (465565)
- Product Name
- Kenkay Extra Relief Moisturising Cream (Export)
- Approval Date
- Oct 23, 2024
TGA
ACTAVANZ lisdexamfetamine dimesilate 20 mg capsules bottle (406915)
- Product Name
- ACTAVANZ lisdexamfetamine dimesilate 20 mg capsules bottle
- Approval Date
- Jan 22, 2024
TGA
ACTAVANZ lisdexamfetamine dimesilate 50 mg capsules bottle (406918)
- Product Name
- ACTAVANZ lisdexamfetamine dimesilate 50 mg capsules bottle
- Approval Date
- Jan 22, 2024
TGA
ACTAVANZ lisdexamfetamine dimesilate 40 mg capsules bottle (406914)
- Product Name
- ACTAVANZ lisdexamfetamine dimesilate 40 mg capsules bottle
- Approval Date
- Jan 22, 2024
TGA
ACTAVANZ lisdexamfetamine dimesilate 70 mg capsules bottle (406916)
- Product Name
- ACTAVANZ lisdexamfetamine dimesilate 70 mg capsules bottle
- Approval Date
- Jan 22, 2024
TGA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found